Evaluation of Fluid Volume in Patients With Refractory Hypotension (Fresh-ER)

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 18, 2020

Primary Completion Date

December 17, 2022

Study Completion Date

December 17, 2022

Conditions
Undifferentated Shock
Interventions
DEVICE

Starling SV

The Starling SV will monitor the change in hemodynamic variables (i.e. CO, SV, HR, SV) as assessed during the initial fluid resuscitation in individuals with hypotension related to infection.

Trial Locations (1)

80204

Denver Health Medical Center, Denver

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Ivor Douglas

OTHER

NCT05101031 - Evaluation of Fluid Volume in Patients With Refractory Hypotension (Fresh-ER) | Biotech Hunter | Biotech Hunter